文献速递神经外周血管MR

FLAIR血管高信号与大脑中动脉狭窄患者梗死及血管病变负荷的相关性

FLAIR vascular hyperintensity: association with infarction and vascular lesion burden in patients with middle cerebral artery stenosis.
PubMed 文献 · Eur Radiol · 2026-03-12

回顾性纳入253例大脑中动脉病变行血管壁成像的患者,分析FLAIR血管高信号(FVH)与梗死及血管病变负荷的关系。梗死、重度狭窄和血管壁明显强化与FVH存在独立相关,联合模型判别FVH存在的AUC为0.803;梗死、重度狭窄、最大壁厚度和最大血管病变长度与更高FVH负荷独立相关,联合模型AUC为0.801。作者认为FVH可能是整合梗死与血管壁病理的潜在MRI生物标志物。

要点

  • 梗死、重度狭窄和血管壁明显强化与FVH存在独立相关,联合模型AUC 0.803,敏感度76.6%、特异度76.7%。
  • 梗死、重度狭窄、最大壁厚度和最大血管病变长度与更高FVH负荷独立相关,联合模型AUC 0.801,敏感度80.8%、特异度70.9%。
  • FVH可能作为常规MRI上易获取的整合性生物标志物,提示其有助风险分层和个体化治疗决策的潜力。

核心结论

  • 梗死和血管病变负荷是与FVH相关的关键因素,提示FVH与潜在血管壁病理之间存在病理生理联系,FVH可能是潜在的整合性MRI生物标志物。

研究设计与样本

  • 回顾性纳入253例连续的大脑中动脉病变且行血管壁成像的患者,采用多变量logistic回归筛选FVH存在或负荷的判别因素,并以AUC、敏感度和特异度评估联合模型的判别能力。

关键影像表现/征象

  • FVH为FLAIR序列上血管高信号,是血流动力学受损和侧支循环缓慢血流的标志。
  • 梗死、重度狭窄和血管壁明显强化与FVH存在独立相关(OR分别为2.995、4.074、2.141,均p<0.05)。
  • 梗死、重度狭窄、最大壁厚度和最大血管病变长度与更高FVH负荷独立相关(OR分别为2.966、8.785、2.344、1.049,均p<0.05)。

诊断标准与关键数值

  • 联合模型(梗死+重度狭窄+血管壁明显强化)判别FVH存在的AUC为0.803(95%CI:0.749-0.850,p<0.001),敏感度76.6%,特异度76.7%。
  • 联合模型(梗死+重度狭窄+最大壁厚度+最大血管病变长度)判别更高FVH负荷的AUC为0.801(95%CI:0.746-0.848,p<0.001),敏感度80.8%,特异度70.9%。

临床应用与阅片要点

  • 作者认为FVH可能作为常规MRI上易获取的生物标志物,整合梗死和特定血管特征,提示其有潜力增强风险分层并指导个体化治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH) is a marker of hemodynamic impairment linked to poor outcomes. However, its underlying vascular pathology remains unclear. We aimed to evaluate the relationships between FVH, infarction, and vascular lesion burden, and explore whether infarction and vascular lesion burden can discriminate FVH presence and burden.

MATERIALS AND METHODS: A total of 253 consecutive patients with middle cerebral artery lesions who underwent vessel wall imaging were retrospectively enrolled. Multivariate logistic regressions were performed to identify discriminatory factors for FVH presence or burden; area under the curve (AUC), sensitivity and specificity assessed the discriminatory ability of combined models.

RESULTS: Infarction, severe stenosis, and vascular wall marked enhancement were independently associated with FVH (ORs 2.995, 4.074, 2.141; all p < 0.05). Infarction, severe stenosis, max wall thickness, and max vascular lesion length were independently correlated with higher FVH burden (ORs 2.966, 8.785, 2.344, 1.049; all p < 0.05). The combined model (infarction + severe stenosis + marked enhancement) discriminated FVH presence with an excellent AUC of 0.803 (95% CI: 0.749-0.850, p < 0.001; sensitivity 76.6%; specificity 76.7%). The combined model (infarction + severe stenosis + max wall thickness + max vascular lesion length) discriminated higher FVH burden with an AUC of 0.801 (95% CI: 0.746-0.848, p < 0.001; sensitivity 80.8%; specificity 70.9%).

CONCLUSION: Infarction and vascular lesion burden are key factors associated with FVH. Our findings suggest a pathophysiological link between FVH and underlying vessel wall pathology, positioning FVH as a potential integrative MRI biomarker.

KEY POINTS: Question While FLAIR vascular hyperintensity (FVH) indicates hemodynamic compromise and slow collateral flow, how the underlying vascular lesion burden contributes to FVH formation remains unclear. Findings Infarction, severe stenosis, and vascular lesion burden features effectively distinguished both FVH presence and higher burden, with combined models demonstrating excellent discriminatory performance. Clinical relevance FVH may serve as a valuable and readily accessible biomarker on conventional MRI that integrates infarction and specific vascular characteristics, suggesting its potential to enhance risk stratification and guide personalized therapeutic decisions in clinical practice.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jiang C, Li Y, Li C, et al. FLAIR vascular hyperintensity: association with infarction and vascular lesion burden in patients with middle cerebral artery stenosis. Eur Radiol. 2026. PMID: 41817708. doi:10.1007/s00330-025-12282-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。